Intrinsiqs

Is Vanda Pharmaceuticals Inc. overvalued?

Vanda Pharmaceuticals Inc. (VNDA) — key valuation metrics and fundamentals.

No verdict
Price
$3.99
Fair value
—
Current P/E
—
Normal P/E
33.5
Market cap
$241.3M
Dividend yield
0.0%
Return on equity
-106.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares VNDA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.